Abstract
A retrospective analysis is presented of a clinician's 10-year experience using isotretinoin as a treatment for severe nodulocystic acne and the spectrum of side effects experienced by patients on a 20 week course of 1 mg/kg/day of the drug.
Get full access to this article
View all access options for this article.